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Abstract We analyzed fatty acid biosynthesis in Chang and
ZR-75-1 cells. Both cell lines could desaturate and further
elongate substrates for v-5 desaturase. ZR-75-1 but not Chang
cells showed v-6 desaturation of 18:2n-6, 18:3n-3, 24:4n-6 and
24:5n-3. In both cell lines, the mRNA abundance can be related
to v-5 or v-6 fatty acid desaturase activities. These results
suggest that desaturase genes could have, at least in part,
independent control mechanisms and that v-6 desaturase
impairment is not specific to any particular step of the fatty
acid metabolic pathways, which may diminish the rationale for
the existence of at least two distinct enzymes. ß 2001 Feder-
ation of European Biochemical Societies. Published by Elsevier
Science B.V. All rights reserved.
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1. Introduction
In mammalian cells, polyunsaturated fatty acids (PUFAs)
are synthesized from essential fatty acid precursors, 18:2n-6,
linoleic acid, and 18:3n-3, K-linolenic acid, through a micro-
somal v-6 desaturation that yields 18:3n-6 and 18:4n-3, and a
subsequent elongation to 20:3n-6 and 20:4n-3, respectively.
These fatty acids are then substrates of a v-5 desaturase
that generates 20:4n-6 and 20:5n-3 which are further elon-
gated twice to 24:4n-6 and 24:5n-3, respectively. In recent
years, Sprecher and co-workers have shown that a second
microsomal v-6 desaturation takes place in the PUFA syn-
thesis on 24:4n-6 and 24:5n-3 [1]. The products of this desat-
uration, 24:5n-6 and 24:6n-3, are converted to 22:5n-6 and
22:6n-3, respectively, by a peroxisomal L-oxidation [1,2].
Most of the enzymology of these metabolic pathways has
been studied, although the genes involved are only beginning
to come to light. Recently, the cloning and expression of
mammalian v-6 and v-5 desaturases have been described [3^
5]. In fact, three genes encoding membrane-anchored proteins
from the human fatty acid desaturase family have been char-
acterized within human chromosomal band 11q12^q13.1.
Their expression pro¢le has also been assessed in various hu-
man tissues [6]. The regulation of these desaturases, in partic-
ular v-6 desaturase, has been explored from di¡erent angles
and found to be associated with hormones, diet, and age [7].
Recent reports have also proposed that certain activators (i.e.
Wy14643) of the transcription factor peroxisome proliferator-
activated receptor isoform K coordinately induce the tran-
scription and mRNA abundance of both v-5 and v-6 desatur-
ases [8].
Results from Cho et al. [4,5] have shown that enzyme ac-
tivity does not always consistently correlate with the quantity
of v-6 desaturase mRNA in di¡erent human tissues, i.e. brain
and liver. Therefore, in order to explore further the relation-
ship between enzyme activity and gene expression in human
cells, this study was designed to assess and compare the ability
of two human cell lines to metabolize n-3 and n-6 PUFAs and
to correlate enzymatic activity with mRNA presence for v-5
and v-6 desaturases.
2. Material and methods
2.1. Cell culture
ZR-75-1 (human mammary carcinoma) and Chang (human adult
liver) cell lines (American Type Culture Collection, Rockville, MD,
USA) were maintained in Dulbecco’s modi¢cation of Eagle’s medium
(DMEM) containing 10% fetal bovine serum in a humidi¢ed atmo-
sphere of 95% air and 5% carbon dioxide at 37‡C. Cell culture media
and supplements were obtained from Gibco BRL (Grand Island, NY,
USA).
2.2. Incubation with radiolabelled fatty acids
Both human cell line cultures were supplemented with fatty acids as
previously described [9]. These conditions were selected based on our
previous experiments in which optimum fatty acid uptake, desatura-
tion, and elongation were detected in mammalian cells in culture [10].
Brie£y, 3U105 cells were plated in 35 mm Petri dishes and allowed to
grow for 24 h. At approximately 90% con£uence, the medium was
removed and the cell monolayers were rinsed twice with fresh serum-
free DMEM medium. Cells were then incubated in DMEM medium
containing 0.27% fatty acid-free bovine serum albumin (BSA, Sigma
Chemical Company, St. Louis, MO, USA) for 18 h prior to the
addition of fatty acids. [1-14C]Linoleic acid (18:2n-6; speci¢c activity
(s.a.) 53 mCi/mmol), [1-14C]K-linolenic acid (18:3n-3; s.a. 52 mCi/
mmol) and [1-14C]dihomo-Q-linolenic acid (20:3n-6; s.a. 52 mCi/
mmol) were purchased from NEN Research Products (Du Pont, Bos-
ton, MA, USA). The radiolabelled and unlabelled fatty acids (Sigma),
pre-dissolved in ethanol, were diluted in DMEM medium containing
0.27% BSA and immediately added to the Petri dishes to give a fatty
acid concentration of 60 WM. The incubation volume was 1.5 ml with
a ¢nal ethanol concentration of 0.1% and total radioactivity of 0.25
WCi. At di¡erent time intervals, between 0.5 and 24 h, the cell mono-
layer was washed three times with phosphate-bu¡ered saline and the
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cells were harvested using a rubber policeman. In separate experi-
ments, [1-14C]24:4n-6 and [1-14C]24:5n-3 (s.a. 55 mCi/mmol for
both fatty acids; ARC, St. Louis, MO, USA) were incubated for
12 h at a ¢nal concentration of 60 WM or 2.8 WM with a total radio-
activity of 0.25 WCi.
Separate dishes of cells were treated under the same conditions with
60 WM unlabelled fatty acid and used for protein determination [11].
2.3. Extraction and lipid analysis
Lipids were extracted from harvested cells and the pooled media
and washings, according to the method of Folch et al. [12]. Aliquots
of the total lipid extracts were taken for radioactivity determination,
whereas other aliquots were methylated using BF3^methanol. The
radiolabelled fatty acid methyl esters (FAME) were analyzed as pre-
viously described [13] using a Hewlett Packard (1090, series II) chro-
matograph equipped with a diode array detector set at 205 nm, a
radioisotope detector (model 171, Beckman, Fullerton, CA, USA)
with a solid scintillation cartridge (97% e⁄ciency for 14C detection)
and a reverse-phase ODS (C-18) Beckman column (250 mmU4.6 mm
i.d.; 5 Wm particle size) attached to a pre-column with a WBondapak
C-18 (Beckman) insert. FAME were separated isocratically with ace-
tonitrile/water (95:5 v/v) at a £ow rate of 1 ml/min and were identi¢ed
by comparison with authentic standards.
2.4. RNA extraction and Northern blot analysis
RNA was isolated from both human cell lines using Trizol0 (Gibco
BRL, Gaithersburg, MD, USA) based on the method of Chomczynski
and Sacchi [14]. Total RNA (5 Wg) from each cell line was size-frac-
tionated in a 1.0% formaldehyde agarose gel. The gel was treated with
50 mM NaOH and 100 mM Tris^HCl, pH 7.0 each for 20 min before
equilibration in 20USSC for 30 min. The Zeta-Probe0 blotting mem-
brane was prepared according to the manufacturer’s instructions (Bio-
Rad, Hercules, CA, USA) and the RNA was transferred overnight at
room temperature with 10USSC. Both UV cross-linking and baking
at 80‡C for 60 min ¢xed the RNA to the membrane. The abundance
of each transcript of interest was determined by sequential hybridiza-
tion using speci¢c cDNA probes corresponding to nucleotide posi-
tions 722^1173 and 262^1006 downstream of the ATG for human
v-5 and v-6 desaturase respectively [4,5], and from nucleotide posi-
tions 71^1053 for the human glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) probe (Clontech, Palo Alto, CA, USA). The probes
were radiolabelled by random priming with [K-32P]dCTP (NEN Life
Science Products, Boston, MA, USA) using DNA Labeling Beads
(Amersham Pharmacia Biotech, Piscataway, NJ, USA) and the unin-
corporated nucleotides removed by exclusion chromatography using
MicroSpin1 Sephadex G-25 columns according to the supplier’s pro-
tocol (Amersham Pharmacia Biotech). Prehybridization and hybridi-
zation were conducted at 42‡C and the membrane was washed under
high stringency conditions (0.1USSC at 65‡C). The membrane was
then exposed to Kodak BioMAX MS ¢lm (Kodak, Rochester, NY,
USA) for an autoradiographic analysis.
3. Results
Fig. 1 shows that the uptake of 18:2n-6, 20:3n-6, or 18:3n-3
was monophasic and the maximum labelling, achieved within
12 h of incubation with all of these PUFAs, was quantita-
tively similar in either Chang or ZR-75-1 cells. The detection
of desaturation and elongation to higher homologues of ra-
diolabelled 18:2n-6, 20:3n-6, or 18:3n-3 increased linearly
with time in both cell lines (data not shown). Two selected
radiochromatograms (Fig. 2) of n-6 metabolites obtained after
a 24 h incubation with [1-14C]18:2n-6 show the capability of
ZR-75-1 cells to produce 18:3n-6 through a v-6 desaturation
system. This fatty acid was elongated to 20:3n-6 which was
further desaturated to 20:4n-6 by v-5 desaturase and then
elongated to 22:4n-6. Two of the higher homologues of this
fatty acid (i.e. 24:4n-6 and 24:5n-6) and the ¢nal product in
the pathway, 22:5n-6, were not detected. The direct elonga-
tion metabolite of 18:2n-6 (i.e. 20:2n-6) was also produced.
Conversely, Chang cells were only able to elongate 18:2n-6
without any v-6 desaturation. Furthermore, no desaturation
products were detected in the supernatant at this or at any
other time point (data not shown).
A comparative percent distribution of radioactivity among
n-6 and n-3 metabolites after 12 h of incubation with either
[1-14C]18:2n-6, [1-14C]18:3n-3, or [1-14C]20:3n-6 expands these
¢ndings (Tables 1, 2 and 5). In Chang cells, the percent of
radioactivity recovered in 18:2n-6 was 1.5-fold higher than in
ZR-75-1 cells (Table 1). The direct elongation product, 20:2n-
6, with a 1.2-fold higher percentage of radioactivity to that
detected in ZR-75-1 cells, made up the balance. [1-14C]18:3n-6
was not detected at this time point nor in the 0.5 or 6 h
incubations. In ZR-75-1 cells, the highest percentage of radio-
activity in n-6 metabolites was found in 20:4n-6.
Similar results were observed when both cell lines were in-
cubated with [1-14C]18:3n-3 (Table 2). In Chang cells, most of
the radioactivity remained in the fatty acid precursor, how-
ever, the balance was made up by elongation products (i.e.
20:3n-3 and 22:3n-3) and a 20:4n-3 isomer at a slightly higher
percentage than that observed with 18:2n-6. In ZR-75-1 cells,
Fig. 1. Percent of radioactivity recovered in Chang and ZR-75-1
cells during a 24 h incubation with 60 WM of radiolabelled polyun-
saturated fatty acids: [1-14C]18:2n-6 (b), [1-14C]20:3n-6 (a) and
[1-14C]18:3n-3 (R). Data are the mean þ S.D. of at least four deter-
minations.
Fig. 2. HPLC radiochromatograms of FAME obtained from total
lipids of Chang and ZR-75-1 cells incubated with [1-14C]18:2n-6
acid for 24 h.
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the distribution of radioactivity was almost identical to that
detected when these cells were incubated with [1-14C]18:2n-6.
The reverse-phase HPLC analysis of PUFAs did not allow us
to distinguish between the 20:4n-3 isomers (i.e. v5;11;14;1720:4
and v8;11;14;1720:4). Thus, the ratio of these fatty acids pro-
duced in ZR-75-1 cells remains unknown.
The v-6 desaturase activity in the ‘Sprecher pathway’ [2]
was also analyzed in both cell lines using custom-made radio-
labelled substrates. Chang cells were unable to desaturate
24:4n-6 or 24:5n-3 to 24:5n-6 and 24:6n-3, respectively, at
either of the test concentrations (Tables 3 and 4). Conversely,
in ZR-75-1 cells, 18.1% of 24:5n-6 and 15.8% of 24:6n-3 were
produced from 24:4n-6 and 24:5n-3, respectively, within 12 h
incubation (Tables 3 and 4). In spite of maximizing the de-
tection of the radiolabelled products by increasing the speci¢c
activity of the substrate by 20 times (when the total concen-
tration was 2.8 WM), no major di¡erences were observed in
the radiolabelled pro¢les in these two cell lines. The radio-
chromatograms also showed peaks that correspond to 14:0,
16:0, and 18:1 which may be de novo synthesis products of
endogenous fatty acids and radiolabelled acetate released by
partial L-oxidation of 24:4n-6 and 24:5n-3 as suggested else-
where [15^17]. In spite of the similar retention times of 22:5n-
6 and 14:0 under these HPLC conditions, the presence of
22:5n-6 in Chang cells was ruled out since the intermediate
metabolite, 24:5n-6, was not detected as it was in ZR-75-1
cells.
When Chang cells were incubated with [1-14C]20:3n-6, a
higher percentage of radioactivity was detected in the direct
elongation metabolite, 22:3n-6, than was in the ZR-75-1 cells
(Table 5). Both cell lines were able to convert 20:3n-6 to
20:4n-6 by v-5 desaturase, followed by two successive rounds
of elongation.
The Northern blots shown in Fig. 3 clearly indicate the
signi¢cant presence of both fatty acid v-5 and v-6 desaturase
transcripts in the ZR-75-1 cell line. Chang liver cells, on the
other hand, expressed only the v-5 desaturase. The integrity
and amount of RNA loaded on the gel was con¢rmed using
the human GAPDH control probe.
4. Discussion
The uptake of PUFAs by these two cell lines was consistent
with that observed in other mammalian cells in vitro [9,18].
The possibility of a di¡erent metabolic fate for each PUFA in
Chang or ZR-75-1 cells due to a di¡erential intracellular fatty
acid concentration is unlikely since all the fatty acids tested
showed similar uptake in both cell lines. As well, the fatty acid
supplementation in the medium did not a¡ect cell number
(approximately 95% of cells were alive) nor the protein con-
tent at any time point (data not shown).
Our ¢ndings in Chang cells showing a lack of v-6 desatur-
ase activity for 18:2n-6, 18:3n-3, 24:4n-6, and 24:5n-3 and a
signi¢cant capability to produce 20:4n-6 by a v-5 desaturase
system support and expand, although not completely, earlier
reports. Indeed, the lack of v-6 desaturation on 18:2n-6 has
been described in several malignant cells in culture and in
microsomes from human tumors [19,20]. However, the direct
or indirect test of v-6 desaturase activity on substrates such as
24:4n-6 and 24:5n-3 has been con¢ned to rat liver hepatocytes
and microsomes [1,16], rat seminiferous tubules [21], or rat
testis cells [17]. It has also been reported that Chang cells as
well as other cell lines (LM and CHO) were not able to pro-
duce higher homologue PUFAs from 18:2n-6 in spite of the
presence of v-5 desaturation [22]. Nevertheless, our data point
to an alternative explanation of PUFA metabolism in Chang
Table 1
Percent of radioactivity recovered in n-6 desaturation and elongation metabolites of [1-14C]18:2n-6 incubated with Chang and ZR-75-1 cells for
12 h
Cells Distribution of radioactivity (%)
18:2 18:3 20:2 20:3 20:4 22:4
Chang 88.2 þ 0.2 ND 11.8 þ 0.2 ND ND ND
ZR-75-1 61.1 þ 1.4 2.1 þ 0.2 9.2 þ 0.5 10.1 þ 0.4 13.7 þ 0.6 2.8 þ 0.5
Values are the mean þ S.D. of at least three determinations. ND: not detected.
Table 2
Percent of radioactivity recovered in n-3 desaturation and elongation metabolites of [1-14C]18:3n-3 incubated with Chang and ZR-75-1 cells for
12 h as described in Section 2
Cells Distribution of radioactivity (%)
18:3 18:4 20:3 20:4* 20:5 22:3 22:5
Chang 83.9 þ 1.9 ND 7.2 þ 0.5 3.0 þ 0.2 ND 2.8 þ 0.3 ND
ZR-75-1 55.3 þ 4.1 2.4 þ 0.4 9.1 þ 0.6 11.4 þ 0.5 13.9 þ 3.9 ND 4.6 þ 0.5
Values are the mean þ S.D. of at least three determinations. ND: not detected. * indicates v5;11;14;1720:4 and/or v8;11;14;1720:4.
Table 3
Percent of radioactivity recovered in n-6 and other fatty acids of Chang and ZR-75-1 cells after a 12 h incubation with [1-14C]24:4n-6
Cells Distribution of radioactivity (%)
24:4 24:5 22:5 14:0 16:0 18:1 unknown
Chang 40.1 þ 2.8 ND ND 17.6 þ 0.3 15.6 þ 2.5 26.7 þ 0.2 ND
ZR-75-1 20.8 þ 1.4 18.1 þ 1.6 10.6 þ 0.8* ^ 16.7 þ 0.8 17.3 þ 1.7 16.5 þ 3.1
Values are the mean þ S.D. of at least three determinations. ND: not detected. * may represent the sum of 22:5n-6 and 14:0, since both
FAME have similar retention times under the present HPLC conditions.
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cells to that previously reported by Maeda et al. regarding the
activities of both v-6 and v-5 desaturases on 18:3n-3 and
20:4n-3 (i.e. v8;11;14;1720:4), respectively [22]. These authors,
using a combination of glass column gas chromatography
and AgNO3^silica gel thin layer plates found that the radio-
activity from 18:3n-3 was distributed mainly in 20:3n-3 and
20:4n-3 (i.e. v8;11;14;1720:4) and slightly in 18:4n-3 indicating
the presence of v-6 desaturase and the absence of v-5 desat-
urase activity for the n-3 PUFA series. Conversely, our data
suggest that Chang cells cannot desaturate 18:3n-3 directly,
but are able to elongate and further desaturate it to 20:3n-3
and then 20:4n-3 (i.e. v5;11;14;1720:4), indicating the absence of
v-6 desaturase and the presence of v-5 desaturase activity for
the n-3 PUFA series.
We base the interpretation of our results on the fact that we
were not able to detect 18:4n-3, even though under the same
experimental conditions the chromatograms for ZR-75-1 cells
showed a well de¢ned peak identi¢ed as this fatty acid. There-
fore, without 18:4n-3, no 20:4n-3 (i.e. v8;11;14;1720:4) could be
produced, which is the substrate for v-5 desaturase in the
standard pathway. As a result of these two observations,
our data suggest that the isomer of 20:4n-3 in the chromato-
grams of Chang cells, produced by the v-5 desaturation of
20:3n-3, was v5;11;14;1720:4. In addition, the inability of Chang
cells incubated with 24:5n-3 to synthesize the ¢nal n-3 meta-
bolic product, 22:6n-3 (Table 4), is in good agreement with
previous experiments which did not detect this fatty acid even
when the cells were supplemented with 50 WM radiolabelled
20:5n-3 [22]. In fact, only a small number of cell lines, such as
hepatocyte, astrocyte, retinoblastoma, and T-cell leukemia,
show the capability to synthesize 22:6n-3 [23].
Overall, our studies suggest that alterations in fatty acid
desaturase activities are not speci¢c to any fatty acid series.
Indeed, in Chang cells, the lack of activity on either n-6 sub-
strate (i.e. 18:2n-6 or 24:4n-6) correlates with a corresponding
lack of activity on its equivalent fatty acid substrates in the n-
3 series (18:3n-3 or 24:5n-3). Data suggest that v-6 desaturase
impairment in this cell line is not speci¢c to any particular
step of the PUFA metabolic pathways, which may diminish
the rationale for the existence of at least two distinct enzymes
[23]. To date, there is no de¢nite proof that the v-6 desaturase
which recognizes 24-carbon substrates is di¡erent from the
enzyme that desaturates 18:2n-6 or 18:3n-3 [24]. In fact,
only three human fatty acid desaturase genes have been
cloned and according to Marquardt et al. the gene that has
not yet been ascribed to a function is unlikely to represent a
second human v-5 or v-6 desaturase [6]. Our data, however,
do not rule out the possibility of the existence of a second v-6
desaturase which is regulated in the same fashion as the one
described herein.
The use of two cell models with distinct PUFA metabolism
allowed us to ¢nd a direct and positive correlation between
mRNA presence and enzyme activity for v-5 and v-6 desatur-
ases. The sizes of the transcripts at 4.3 kb and 3.1 kb, respec-
tively, agree well with those reported earlier in human tissues
[4^6]. Our ¢ndings in Chang cells showing the lack of v-6
Table 4
Percent of radioactivity recovered in n-3 and other fatty acids of Chang and ZR-75-1 cells after a 12 h incubation with [1-14C]24:5n-3
Cells Distribution of radioactivity (%)
24:5 24:6 14:0 16:0 18:1 unknown
Chang 33.8 þ 2.3 ND 19.6 þ 1.6 16.4 þ 0.9 30.2 þ 1.5 ND
ZR-75-1 18.9 þ 3.1 15.8 þ 1.3 12.5 þ 0.8 19.3 þ 1.8 18.7 þ 1.3 7.8 þ 1.4
Values are the mean þ S.D. of at least three determinations. ND: not detected.
Table 5
Percent of radioactivity recovered in n-6 desaturation and elongation metabolites of [1-14C]20:3n-6 incubated with Chang and ZR-75-1 cells for
12 h
Cells Distribution of radioactivity (%)
20:3 20:4 22:3 22:4 24:4
Chang 71.1 þ 0.7 17.9 þ 0.5 4.0 þ 0.5 5.9 þ 0.3 Tr
ZR-75-1 70.8 þ 0.7 15.2 þ 0.3 2.03 þ 0.3 4.5 þ 0.4 5.7 þ 0.6
Values are the mean þ S.D. of at least three determinations. Tr: traces.
Fig. 3. mRNA expression of human v-5 and v-6 desaturase genes
in (1) ZR-75-1 and (2) Chang cells by Northern blots. Each lane
contains 5 Wg of total RNA. v-5 and v-6 desaturase mRNA tran-
scripts are shown at 4.3 and 3.1 kb, respectively. GAPDH was used
as an internal RNA loading control.
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desaturase activity for any substrate and a corresponding ab-
sence of mRNA, but, with signi¢cant v-5 desaturase activity
and its mRNA, are the ¢rst to suggest that v-5 and v-6 de-
saturase genes have, at least in part, independent control
mechanisms. However, our data are not su⁄cient to distin-
guish between direct transcriptional control or RNA tran-
script stability.
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